Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- eQ8Health Corporation d/b/a CareONE Concierge
- Study ID
- NCT07222605
- Status
- Enrolling By Invitation
Conditions
- Alzheimer Disease
- Cortico Basal Degeneration
- Dementia
- Frontotemporal Dementia
- Neurological Diseases or Conditions
- Parkinson Disease
- Posterior Cortical Atrophy (PCA)
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 100 Years
- Healthy Volunteers
- Not accepted
Interventions
- MemorEM — DEVICEThe MemorEM device delivers 915MHz electromagnetic waves to the head via emitters in a cap worn on the head and powered by a control box and battery worn on the arm.
Study Details
Primary Objective: The primary objective of this pilot study is to gain voluntary feedback from patients with neurological diseases and their caregivers regarding their experiences using the MemorEM head device. This information may help in new designs of the MemorEM and suggest ways to increase compliance for future clinical trials and eventual commercialization. Secondary Objective: The secondary objective is to note areas of potential improvement in the progression of the subject's neurological disease and identify the potential for the MemorEM to treat neurological diseases other than Alzheimer's disease. The investigators are also interested in Alzheimer's variants like those with ApoE4 alleles (none of the participants in the 8-person pilot were Apo-E4 positive), known mutations causing early onset Alzheimer's, and Posterior Cortical Atrophy.
Key Dates
- Start date
- Dec 1, 2025
- Status verified
- Feb 2026
- Primary completion
- Dec 15, 2027
- Completion
- Dec 15, 2029
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Active Comparator: Patient Experience Arm
Primary Outcome Measure
Patient and caregiver reports on device design and use [ Time Frame: Surveys will be given starting a month after beginning treatment and monthly thereafter over the course of up to two years. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CareONE Concierge | Atlanta | Georgia | 30305 | - |
Find similar trials in Atlanta, GA
Related Studies
- Effects of Stimulation Patterns of Deep Brain StimulationEnrolling By Invitation · Duke University · Gainesville, Florida
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- North American Prodromal Synucleinopathy ConsortiumEnrolling By Invitation · Washington University School of Medicine · Sun City, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama